AVEO Oncology (NASDAQ: AVEO) recently announced the FDA approval of FOTIVDA. So, the stock has been on the radar of several investors are commercialization will commence in the next couple of months. Now, the company is looking to take the treatment another step forward, with an announcement this morning that it has entered into a … Read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is headed up in the premarket hours, setting the stage for significant gains for the second trading session in a row. The gains started when the company announced the approval of a new drug for the treatment of cancer by the FDA. Here’s what’s going on: Skip to What You … Read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) had a strong run in the market earlier in the week as acquisition rumors took hold. Unfortunately however, the stock is down in a big way this morning after the company announced offering news. Not only does the offering dilute current shareholders, it serves as a point of clarity when … Read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is having a great start to the trading session in the pre-market this morning, following up on the strong gains that we saw yesterday. Today’s gains seem to be the result of data that was released. Today, we’ll talk about: The data release; what we’re seeing from AVEO stock as … Read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is making a run for the top in the market this morning. However, if you’re looking for press releases or SEC filings that may be the reason for the gains, you may find yourself upset. There’s nothing out there. Nonetheless, there is a good reason for the movement. Today, we’ll … Read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is having a great start to the trading session this morning, and for good reason. Late last week, the company announced the presentation of positive data at the 2019 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium. As you could imagine, the news proved to be exciting. Today, … Read more
AVEO Oncology (NASDAQ: AVEO) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has initiated the analysis of pivotal clinical data, exciting investors who are pushing the stock on a run for the top. Today, we’ll talk about: The clinical update; what we’re … Read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is having an incredibly strong start to the trading session this morning, following up on strong gains seen from the stock yesterday. The gains started after the comapny announced that it will be presenting at two coming investor conferences. Today, we’ll talk about: The news; what we’re seeing from AVEO … Read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is having a strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced new guidance with regard to the timing of the TIVO-3 clinical study. Of course, the new guidance pushed the time lin up, exciting investors and sending the stock … Read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that it has received a positive recommendation from NICE in the United Kingdom. Of course, this led to excitement among investors who are pushing the stock toward the top. Today, we’ll talk … Read more